JP3385293B2 - Altocarpine-containing antibacterial and preservatives and cosmetics - Google Patents
Altocarpine-containing antibacterial and preservatives and cosmeticsInfo
- Publication number
- JP3385293B2 JP3385293B2 JP23226694A JP23226694A JP3385293B2 JP 3385293 B2 JP3385293 B2 JP 3385293B2 JP 23226694 A JP23226694 A JP 23226694A JP 23226694 A JP23226694 A JP 23226694A JP 3385293 B2 JP3385293 B2 JP 3385293B2
- Authority
- JP
- Japan
- Prior art keywords
- altocarpine
- test
- cosmetics
- antibacterial
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 23
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 22
- 239000003755 preservative agent Substances 0.000 title description 7
- 206010000496 acne Diseases 0.000 claims description 20
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 19
- 208000001840 Dandruff Diseases 0.000 claims description 16
- 239000003242 anti bacterial agent Substances 0.000 claims description 10
- 239000004599 antimicrobial Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 210000004209 hair Anatomy 0.000 claims description 8
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 241000191967 Staphylococcus aureus Species 0.000 claims description 6
- 244000063299 Bacillus subtilis Species 0.000 claims description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 5
- 238000012360 testing method Methods 0.000 description 26
- 241000894006 Bacteria Species 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- -1 foundation Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 9
- 241000186427 Cutibacterium acnes Species 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 229940055019 propionibacterium acne Drugs 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 235000013305 food Nutrition 0.000 description 8
- 235000012149 noodles Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000009422 growth inhibiting effect Effects 0.000 description 6
- 229960001416 pilocarpine Drugs 0.000 description 6
- 239000000344 soap Substances 0.000 description 6
- 244000025352 Artocarpus heterophyllus Species 0.000 description 5
- 235000008725 Artocarpus heterophyllus Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000002781 deodorant agent Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000015067 sauces Nutrition 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000004278 EU approved seasoning Substances 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 238000003113 dilution method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 235000013580 sausages Nutrition 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 235000013555 soy sauce Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical group OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical group OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical group OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- XRYVAQQLDYTHCL-IQMFZBJNSA-N Sophoraflavanone G Natural products C1([C@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CC=C(C)C)C(C)=C)=CC=C(O)C=C1O XRYVAQQLDYTHCL-IQMFZBJNSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000013040 bath agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 230000001013 cariogenic effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical group C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 239000000118 hair dye Substances 0.000 description 2
- 239000008266 hair spray Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000005722 itchiness Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 239000003264 margarine Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000013077 scoring method Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XRYVAQQLDYTHCL-CMJOXMDJSA-N sophoraflavanone G Chemical compound C1([C@@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CC=C(C)C)C(C)=C)=CC=C(O)C=C1O XRYVAQQLDYTHCL-CMJOXMDJSA-N 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FZKCAHQKNJXICB-UHFFFAOYSA-N 2,1-benzoxazole Chemical compound C1=CC=CC2=CON=C21 FZKCAHQKNJXICB-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical compound O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- AAXZLRPBJQFZQA-UHFFFAOYSA-N Artocarpin Natural products CC(C)=CCC=1C(=O)C=2C(O)=C(CC=C(C)C)C(OC)=CC=2OC=1C1=CC=C(O)C=C1O AAXZLRPBJQFZQA-UHFFFAOYSA-N 0.000 description 1
- 241000218232 Artocarpus Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Chemical group OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Chemical group OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000006311 Pyoderma Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Chemical group 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- KRGDFVQWQJIMEK-RMKNXTFCSA-N artocarpin Chemical compound CC(C)=CCC=1C(=O)C=2C(O)=C(\C=C\C(C)C)C(OC)=CC=2OC=1C1=CC=C(O)C=C1O KRGDFVQWQJIMEK-RMKNXTFCSA-N 0.000 description 1
- 108010034967 artocarpin lectin Proteins 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 150000001615 biotins Chemical group 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229940075285 dandruff control Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 235000020993 ground meat Nutrition 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 201000004614 iritis Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000011242 neutrophil chemotaxis Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Chemical group 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Chemical group 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000009160 phytotherapy Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Chemical group 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical group 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、アルトカルピンを含有
する新規な抗菌・防腐剤及び化粧料への応用に関するも
のである。TECHNICAL FIELD The present invention relates to a novel antibacterial / preservative containing altocarpine and its application to cosmetics.
【0002】その利用分野としては、医薬品・医薬部外
品或は化粧品分野(人及びその他の動物用に用いる各種
製剤も含む)の各種化粧料として利用でき、具体的に
は、化粧水、ローション、シェイビングローション、乳
液、クリーム(軟膏を含む)、日焼け止めクリーム、フ
ァンデーション、オイル、パック、石鹸(薬用石鹸も含
む)、ボディソープ、爪化粧品類、眉目化粧品類、香水
類、洗顔料類、口腔用類(歯磨き、マウスウオッシュ
等)、液臭・防臭防止剤、浴用剤、シャンプー、リン
ス、ヘアートニック、ヘアースプレー、染毛料などへの
応用が上げられる。又、抗菌・防腐剤としては、各種形
態の経口薬剤、繊維製品(シーツ類、衣類等)、更に衛
生綿類、ウエットティシュや拭き取り用ペーパー類、除
菌用クロス等の不織布に、又、口腔用組成物(ガム、キ
ャンデー等)やかまぼこ、ちくわ等の水産ねり製品、ソ
ーセージ、ハム等の畜産製品、洋菓子類、和菓子類、生
めん、中華めん、ゆでめん、そば等のめん類、ソース、
醤油、たれ等の調味料、漬物、そう菜等、一般的な飲食
類への使用が上げられる。It can be used as various cosmetics in the fields of pharmaceuticals, quasi-drugs, and cosmetics (including various preparations used for humans and other animals), and specifically, lotions and lotions. , Shaving lotion, emulsion, cream (including ointment), sunscreen, foundation, oil, pack, soap (including medicated soap), body soap, nail cosmetics, eyebrow cosmetics, perfume, face wash, oral cavity Applications include applications (toothpaste, mouthwash, etc.), liquid odors / deodorants, bath agents, shampoos, conditioners, hair tonics, hair sprays, hair dyes, etc. As antibacterial and antiseptic agents, various forms of oral agents, textiles (sheets, clothes, etc.), non-woven fabrics such as sanitary cotton, wet tissues and wipes, disinfectant cloth, etc. Composition (gum, candy, etc.), fish paste products such as kamaboko and chikuwa, livestock products such as sausage and ham, western confectionery, Japanese confectionery, raw noodles, Chinese noodles, boiled noodles, noodles such as buckwheat, sauces,
It can be used for general food and drink such as soy sauce, seasonings such as sauces, pickles, soybeans, etc.
【0003】[0003]
【従来の技術】これまで微生物の増殖による食品・医薬
品・化粧品類等の抗菌・防腐剤としては、ソルビン酸、
デヒドロ酢酸及びその塩、パラオキシ安息香酸誘導体な
どがよく使用されているが、安全性の点で問題があり、
添加量や対象食品が制限(例えば、ソルビン酸及びその
塩の食品への配合上限は0.2%であり、デヒドロ酢酸
及びその塩は、チーズ、バター及びマーガリンにのみ使
用可能、又、パラオキシ安息香酸メチルナトリウムの化
粧品類への配合上限は1.0%)されていた。2. Description of the Related Art So far, sorbic acid has been used as an antibacterial / preservative agent for foods, pharmaceuticals, cosmetics, etc. due to the growth of microorganisms.
Dehydroacetic acid and its salts, paraoxybenzoic acid derivatives and the like are often used, but there is a problem in safety,
Addition amount and target foods are limited (for example, the upper limit of compounding sorbic acid and its salts in foods is 0.2%, dehydroacetic acid and its salts can be used only in cheese, butter and margarine, and paraoxybenzoic The upper limit of the content of sodium methyl acidate in cosmetics was 1.0%).
【0004】又、微生物の増殖を抑制するために、生体
では皮膚や粘膜では物理的若しくは殺菌性物質や粘液の
分布といった化学的な方法によって、微生物の侵入を抑
え、更に、生体内に侵入した微生物に対しては、免疫グ
ロブリンによる付着阻止、食細胞による食作用、リゾチ
ームによる溶菌作用等、先天的で非特異的な感染抵抗や
特定の病原菌に対する免疫応答などによって抵抗が行わ
れている。In order to suppress the growth of microorganisms, the invasion of microorganisms is suppressed by a chemical method such as physical distribution in the skin or mucous membranes of living organisms or the distribution of bactericidal substances or mucus. Resistance to microorganisms is caused by innate and nonspecific infection resistance, immune response to specific pathogenic bacteria, such as adhesion inhibition by immunoglobulin, phagocytosis by phagocytic cells, lytic action by lysozyme, and the like.
【0005】しかしながら、もし、細菌の感染力が生体
における抵抗力を上回ってしまえば、生体内では感染症
状が現れ、例えば、黄色ブドウ球菌による膿皮症などの
感染性皮膚炎、食中毒、敗血症、枯草菌は結膜炎、虹彩
炎、大腸菌では尿路感染症、下痢症など、又、アクチノ
バシルスなどによる歯周病、う触原菌による虫歯、更に
ニキビ菌(プロピオニバクテリウム アクネス)、フケ
菌(ピティロスポルムオバーレ)などによるニキビ、フ
ケ又はフケに伴うカユミ等、様々な症状を起こす危険性
がある。However, if the infectivity of bacteria exceeds the resistance in the body, infectious symptoms appear in the body, for example, infectious dermatitis such as pyoderma due to Staphylococcus aureus, food poisoning, sepsis, Bacillus subtilis is conjunctivitis, iritis, Escherichia coli is urinary tract infection, diarrhea, etc., periodontal disease due to Actinobacillus, cariogenic dental caries, and acne bacterium (Propionibacterium acnes), dandruff There is a risk of causing various symptoms such as acne due to (Pitirosporum ovale), dandruff or itching due to dandruff.
【0006】特に思春期においては、ニキビやフケの発
症を引き起こすことが多く、ニキビは病名を尋常性ざ瘡
と言い、臨床学的には毛襄脂腺系を中心に毛孔に起こる
慢性の炎症性変化と定義され、頭皮のフケは皮表皮脂、
表皮層の角化物、汗腺分泌物等が絡み合い、皮脂腺等の
分泌物の亢進により発生するとされている。[0006] Particularly during adolescence, acne and dandruff often occur, and the name of acne is called acne vulgaris. Clinically, chronic inflammation occurs in the pores mainly in the pilosebaceous system. It is defined as sex change, dandruff on the scalp
It is said that keratinized substances in the epidermis layer, sweat gland secretions and the like are entangled with each other and the secretions such as sebaceous glands are enhanced.
【0007】そこで、ニキビやフケの発症原因につい
て、皮脂の分泌能との関係から見ると、皮脂中のトリグ
リセライドが、毛包管内にプロピオニバクテリウム ア
クネス、又はピティロスポルム オバーレが侵入するこ
とによって、リパーゼの産生が亢進し、これによって、
グリセロールと遊離脂肪酸の生成が高められ、この際に
生成した過剰な遊離脂肪酸によって、面皰形成作用、炎
症惹起作用が特に強く見られる。[0007] From the viewpoint of the cause of acne and dandruff in relation to the secretory function of sebum, triglyceride in sebum causes lipase by invasion of Propionibacterium acnes or Pitirosporum ovale into the hair follicle canal. The production of
The production of glycerol and free fatty acids is enhanced, and due to the excess free fatty acids produced at this time, a comedone forming action and an inflammation inducing action are particularly strongly observed.
【0008】元来、プロピオニバクテリウム アクネ
ス、ピティロスポルム オバーレ共に、脂質依存性、且
つ、好脂質性であることから、皮脂量が毛包管内に増加
して貯留することにより、プロピオニバクテリウム ア
クネス、ピティロスポルム オバーレも次第に増殖す
る。尚、この他にも、プロピオニバクテリウム アクネ
ス、ピティロスポルム オバーレによる好中球走化能や
補体の活性化因子、又、その菌の産生物であるプロテア
ーゼ、リパーゼ、ヒアルロニダーゼ等による毛包上皮の
破壊、炎症の惹起等も新しい仮説として提唱されてい
る。Originally, both Propionibacterium acnes and Pitirosporum ovale are lipid-dependent and lipophilic, so that the amount of sebum increases and accumulates in the hair follicle tube, and thus Propionibacterium acnes. , Pitirosporum Obare also grows gradually. In addition, in addition to these, Propionibacterium acnes, neutrophil chemotaxis by Pitirosporum ovale and activator of complement, as well as protease, lipase, hyaluronidase, etc. of hair follicle epithelium produced by the bacterium. Destruction and induction of inflammation have also been proposed as new hypotheses.
【0009】よって、ニキビの発生においては、病巣部
のニキビ菌(プロピオニバクテリウム アクネス)の生
育を阻止することがニキビの治療には重要であり、フケ
又はフケに伴うカユミの発生については、病巣部のフケ
菌(ピティロスポルム オバーレ)の生育を阻止するこ
とがフケ、カユミの治療につながるものである。Therefore, in the development of acne, it is important for the treatment of acne to prevent the growth of acne bacterium (Propionibacterium acnes) in the lesion area. Preventing the growth of the dandruff fungus (Pitirosporum ovale) in the lesion area leads to the treatment of dandruff and kayumi.
【0010】従って、生体内外における感染症の予防や
治療に対して、これまで様々な薬物が使用されて来た
が、その大半を占める抗生物質や合成抗菌・防腐剤は、
確かにその効果は強いが、安全性の面で問題があり、こ
れらの使用には厳重な注意が必要で、その効力などの面
において、更に有効な物質が求められていた。[0010] Therefore, various drugs have been used for the prevention and treatment of infectious diseases in vivo and in vivo, but most of them are antibiotics and synthetic antibacterial / preservatives.
Certainly, its effect is strong, but there is a problem in terms of safety, and strict caution is required for its use, and a more effective substance has been required in terms of its efficacy.
【0011】[0011]
【発明が解決しようとする課題】そこで、本発明者ら
は、細菌類による感染症、疾患に対して抗菌、防腐効果
があり、且つ、各種分野に利用しても安全であるものに
ついて、各種の植物抽出液より得られる成分を検討し、
追求を積み重ねてきた。Therefore, the inventors of the present invention have selected various substances that have antibacterial and antiseptic effects against infectious diseases and diseases caused by bacteria and are safe to use in various fields. Consider the ingredients obtained from the plant extract of
The pursuit has been accumulated.
【0012】[0012]
【課題を解決するための手段】すなわち、本発明者ら
は、上記事情に鑑み、アルトカルピン(Artocarpin)が
各種の細菌に対して、強い抗菌・防腐効果があることを
確認、且つ、人又は動物に対して安全である、新規な抗
菌・防腐剤及び各種化粧料に応用することが非常に有効
であることを発見し、本発明を完成した。尚、以下に本
発明に至る経過を説明する。[Means for Solving the Problems] That is, in view of the above circumstances, the present inventors have confirmed that Artocarpin has a strong antibacterial / antiseptic effect against various bacteria, and The present invention was completed by discovering that it is very effective to apply to a new antibacterial / preservative and various cosmetics which are safe for animals. The process leading to the present invention will be described below.
【0013】本発明のアルトカルピンは、式1に示され
る構造を有するフラボノイド化合物であり、主にジャッ
クフルーツなどクワ科アルトカルプス(Artocarpus Gen
us)属植物に含まれる成分であるが、本発明のアルトカ
ルピンは特定植物から得られるものに限定されるもので
はなく、更に、化学的合成法によって得られたものでも
使用可能であり、又、精製・製造法は公知の精製・製造
法を採用しても何等差し支えない。The altocarpine of the present invention has the formula 1
It is a flavonoid compound with a structure that is mainly related to Artocarpus Gen
us) is a component contained in a genus plant, but the altocarpine of the present invention is not limited to those obtained from a specific plant, and those obtained by a chemical synthesis method can also be used. As for the refining / manufacturing method, any known refining / manufacturing method may be used.
【化1】式1 [Formula 1] Formula 1
【0014】更に、アルトカルピンは、これをそのま
ま、或いは溶媒として有機溶媒、水又は熱水を用いた
り、必要に応じて、有機溶媒又は水との混合溶媒に溶解
させた状態でも使用でき、有機溶媒抽出と水抽出とが組
み合わされた状態でも使用できる。有機溶媒としてはメ
タノール、エタノール、n−ブタノール、アセトン、酢
酸エチル、n−ヘキサン、1,3−ブチレングリコー
ル、プロピレングリコール、ジエチルエーテル、ジメチ
ルエーテル、クロロホルムなどを用いることができ、形
態は溶液状、ペースト状、ゲル状、粉末状として用いる
ことができる。Further, altocarpine can be used as it is or in the state of using an organic solvent, water or hot water as a solvent, or if necessary dissolved in an organic solvent or a mixed solvent with water. It can also be used in a combination of solvent extraction and water extraction. As the organic solvent, methanol, ethanol, n-butanol, acetone, ethyl acetate, n-hexane, 1,3-butylene glycol, propylene glycol, diethyl ether, dimethyl ether, chloroform or the like can be used, and the form is a solution or paste. It can be used in the form of gel, gel or powder.
【0015】尚、アルトカルピンは、多くの場合、その
ままの状態で利用できるが、必要ならば、その効力に影
響のない範囲で脱臭、脱色等の精製処理を加えても良
い。又、脱臭、脱色等の精製処理手段としては、活性炭
カラムなどを用いれば良く、一般的に適用される通常の
手段を任意に選択して行えば良い。In most cases, altocarpine can be used as it is, but if necessary, purification treatment such as deodorization and decolorization may be added within a range that does not affect its efficacy. Further, as a purification treatment means for deodorization, decolorization, etc., an activated carbon column or the like may be used, and an ordinary means generally applied may be arbitrarily selected.
【0016】本発明のアルトカルピンは、そのままでも
利用できるが、抗菌・防腐剤又は化粧料として配合する
場合の含有量は、抗菌・防腐剤又は化粧料の種類、期待
される作用の程度によって若干異なる。通常、2ppm
以上、好ましくは、20ppm以上が良い。The altocarpine of the present invention can be used as it is, but the content in the case of being compounded as an antibacterial / preservative or cosmetic composition may vary depending on the kind of the antibacterial / preservative composition or the expected degree of action. different. Usually 2ppm
As described above, preferably 20 ppm or more.
【0017】又、本発明のアルトカルピンを配合した抗
菌・防腐剤又は化粧料には、本発明の効果を損なわない
範囲内で、食品、化粧品、医薬品、医薬部外品等に一般
的に用いられる各種成分、例えば、砂糖、練乳、小麦
粉、ショートニング、食塩、ブドウ糖、鶏卵、バター、
マーガリン、水飴、カルシウム、鉄分、調味料、香辛料
や油分(動植物油、鉱物油、エステル油、ワックス油、
シリコン油、高級アルコール、リン脂質類、脂肪酸類
等)、界面活性剤(アニオン性、カチオン性、両性又は
非イオン性界面活性剤)、ビタミン類(ビタミンA群、
ビタミンB群、葉酸類、ニコチン酸類、パントテン酸
類、ビオチン類、ビタミンC群、ビタミンD群、ビタミ
ンE群、その他フェルラ酸、γ−オリザノール等)、紫
外線吸収剤(p−アミノ安息香酸、アントラニル、サル
チル酸、クマリン、ベンゾトリアゾール、テトラゾー
ル、イミダゾリン、ピリミジン、ジオキサン、フラン、
ピロン、カンファー、核酸、アラントイン及びそれらの
誘導体、アミノ酸系化合物、シコニン、バイカリン、バ
イカレイン、ベルベリン等)、抗酸化剤(ステアリン酸
エステル、ノルジヒドログアセレテン酸、ジブチルヒド
ロキシトルエン、ブチルヒドロキシアニソール、パラヒ
ドロキシアニソール、没食子酸プロピル、セサモール、
セサモリン、ゴシポール等)、増粘剤(ヒドキシエチル
セルロース、エチルセルロース、カルボキシエチルセル
ロース、メチルセルロース、カルボキシメチルセルロー
ス、カルボキシメチルセルロースナトリウム、ヒドキシ
プロピルセルロース、ニトロセルロース、ポリビニルア
ルコール、ポリビニルメチルエーテル、ポリビニルピロ
リドン、ポリビニルメタアクリレート、ポリアクリル酸
塩、カルボキシビニルポリマー、アラビアゴム、トラガ
ントゴム、寒天、カゼイン、デキストリン、ゼラチン、
ペクチン、デンプン、アルギン酸及びその塩等)、保湿
剤(プロピレングリコール、1,3−ブチレングリコー
ル、ポリエチレングリコール、グリセリン、コンドロイ
チン硫酸及びその塩、ヒアルロン酸及びその塩、乳酸ナ
トリウム等)又、その他、低級アルコール、多価アルコ
ール、水溶性高分子、pH調整剤、防腐・防バイ剤、着
色料、香料、清涼剤、安定化剤、動・植物抽出物、動・
植物性蛋白質及びその分解物、動・植物性多糖類及びそ
の分解物、動・植物性糖蛋白質及びその分解物、微生物
培養代謝成分、血流促進剤、消炎剤、抗炎症剤、抗アレ
ルギー剤、細胞賦活剤、アミノ酸及びその塩、角質溶解
剤、収斂剤、創傷治療剤、増泡剤、口腔用剤、消臭・脱
臭剤、乳化剤等と共に配合し、併用して用いることもで
きる。The antibacterial / antiseptic agent or cosmetic containing the altocarpine of the present invention is generally used in foods, cosmetics, pharmaceuticals, quasi-drugs, etc. within a range not impairing the effects of the present invention. Various ingredients used, such as sugar, condensed milk, flour, shortening, salt, glucose, chicken eggs, butter,
Margarine, starch syrup, calcium, iron, seasonings, spices and oils (animal and vegetable oils, mineral oils, ester oils, wax oils,
Silicon oil, higher alcohols, phospholipids, fatty acids, etc., surfactants (anionic, cationic, amphoteric or nonionic surfactants), vitamins (vitamin A group,
Vitamin B group, folic acid, nicotinic acid, pantothenic acid, biotins, vitamin C group, vitamin D group, vitamin E group, other ferulic acid, γ-oryzanol, etc., ultraviolet absorber (p-aminobenzoic acid, anthranil, Salicylic acid, coumarin, benzotriazole, tetrazole, imidazoline, pyrimidine, dioxane, furan,
Pyrone, camphor, nucleic acid, allantoin and their derivatives, amino acid compounds, shikonin, baicalin, baicalein, berberine, etc., antioxidants (stearate, nordihydroguaselethenoic acid, dibutylhydroxytoluene, butylhydroxyanisole, para) Hydroxyanisole, propyl gallate, sesamol,
Sesamolin, gossypol, etc.), thickener (hydroxyethyl cellulose, ethyl cellulose, carboxyethyl cellulose, methyl cellulose, carboxymethyl cellulose, carboxymethyl cellulose sodium, hydroxypropyl cellulose, nitrocellulose, polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, polyvinyl methacrylate, Polyacrylate, carboxyvinyl polymer, gum arabic, gum tragacanth, agar, casein, dextrin, gelatin,
Pectin, starch, alginic acid and its salts), moisturizers (propylene glycol, 1,3-butylene glycol, polyethylene glycol, glycerin, chondroitin sulfate and its salts, hyaluronic acid and its salts, sodium lactate, etc.) Alcohol, polyhydric alcohol, water-soluble polymer, pH adjuster, antiseptic / antifungal agent, colorant, fragrance, cooling agent, stabilizer, animal / plant extract, animal / animal
Vegetable protein and its degradation product, animal / vegetable polysaccharide and its degradation product, animal / vegetable glycoprotein and its degradation product, microbial culture metabolic component, blood flow promoter, anti-inflammatory agent, anti-inflammatory agent, anti-allergic agent , A cell activating agent, an amino acid and its salt, a keratolytic agent, an astringent agent, a wound healing agent, a foaming agent, an oral agent, a deodorant / deodorant, an emulsifier and the like, and they can be used in combination.
【0018】又、本発明のアルトカルピンを配合した化
粧料の剤型については、任意であり、常法により配合
し、例えば、化粧水、クリーム、軟膏、ローション、シ
ェイビングローション、乳液、クリーム(軟膏を含
む)、日焼け止めクリーム、ファンデーション、オイ
ル、パック、石鹸(薬用石鹸も含む)、ボディソープ、
爪化粧品類、眉目化粧品類、香水類、洗顔料類、口腔用
類(歯磨き、マウスウオッシュ等)、液臭・防臭防止
剤、浴用剤、シャンプー、リンス、ヘアートニック、ヘ
アースプレー、染毛料等の剤型とすることができる。The dosage form of the cosmetic composition containing the altocarpine of the present invention is arbitrary and may be prepared by a conventional method, for example, lotion, cream, ointment, lotion, shaving lotion, emulsion, cream (ointment). , Sunscreen, foundation, oil, pack, soap (including medicated soap), body soap,
Nail cosmetics, eyebrow cosmetics, perfumes, facial cleansers, oral products (toothpaste, mouthwash, etc.), liquid odors / deodorants, bath agents, shampoos, rinses, hairnics, hair sprays, hair dyes, etc. It can be a dosage form.
【0019】又、本発明のアルトカルピンを配合した抗
菌・防腐剤の剤型については、任意であり、常法により
配合し、例えば、経口薬剤、繊維製品(シーツ類、衣類
等)、更に衛生綿類、ウエットティシュや拭き取り用ペ
ーパー類、除菌用クロス等の不織布に、又、口腔用組成
物(ガム、キャンデー等)やかまぼこ、ちくわ等の水産
ねり製品、ソーセージ、ハム等の畜産製品、洋菓子類、
和菓子類、生めん、中華めん、ゆでめん、そば等のめん
類、ソース、醤油、たれ等の調味料、漬物、そう菜等、
一般的な飲食類の剤型とすることができる。The dosage form of the antibacterial / antiseptic agent containing the altocarpine of the present invention is arbitrary and may be prepared by a conventional method. Cotton, wet tissues, wipes, non-woven fabrics such as sterilizing cloth, and oral compositions (gum, candy, etc.), fish paste products such as kamaboko, chikuwa, sausage, ham and other livestock products, Western confectionery,
Japanese confectionery, raw noodles, Chinese noodles, boiled noodles, noodles such as buckwheat, sauce, soy sauce, seasonings such as sauces, pickles, soy sauce, etc.,
It may be a general dosage form for food and drink.
【0020】更に、本発明のアルトカルピンを配合した
抗菌・防腐剤及び化粧料の配合する場合の形態は、任意
であり、溶液状、クリーム状、ペースト状、ゲル状、ジ
ェル状、泡状、固形状又は粉末状として用いることがで
きる。Further, the form of the antibacterial / antiseptic agent and the cosmetics containing the altocarpine of the present invention may be any form, such as solution, cream, paste, gel, gel, foam, It can be used in solid or powder form.
【0021】尚、同日付け出願のアルトカルピンを必須
成分として含有するジャックフルーツ抽出物、又は、ソ
フォラフラバノンGを必須成分として含有するクジン抽
出物等、アルトカルピン又はソフォラフラバノンGを含
有するものであれば、いずれを用いても良く、又、併用
して、抗菌・防腐剤及び化粧料に配合して用いることが
できる。The jackfruit extract containing altocarpine as an essential component of the same date, the kujin extract containing sophoraflavanone G as an essential component, and the like containing altocarpine or sophoraflavanone G. Any of these may be used, or they may be used in combination with antibacterial and antiseptic agents and cosmetics.
【0022】[0022]
【実施例】以下に、実施例をもってより詳しく述べる
が、以下によって示される方法は、後述の作用等の確認
試験において用いたものであり、これに限定されるもの
ではない。EXAMPLES The present invention will be described in more detail with reference to the following examples, but the method described below is used in the confirmation test of the action and the like described later, and is not limited to this.
【0023】実施例1:ジャックフルーツからのアルト
カルピンの確認Example 1: Confirmation of altocarpine from jackfruit
【0024】ジャックフルーツの木材1kgを粉砕し
て、アセトン10Lを加え、約75℃にて3時間、加熱
還流抽出し、冷却後、濾過して固・液分離を行い、分離
した抽出液を減圧濃縮して、アセトン除去後、濃縮した
濃縮したエキスを、シリカゲルカラムクロマトグラフィ
ー(メルク社製)に通し、次に示す各抽出溶媒(ベンゼ
ン、クロロホルム、酢酸エチル、アセトン、メタノー
ル)で順次溶出し、溶出液を得る。得られた各溶出フラ
クションについて、抗菌活性におけるスクリーニングを
行ったところ、クロロホルム溶出フラクションに強い活
性が見られた。そこで、この溶出フラクションについて
成分検索を行ったところ、アルトカルピンが主成分とし
て含有されていることが確認でき、再度、アルトカルピ
ンについて抗菌試験を行った結果、強い抗菌効果が見ら
れた。1 kg of jackfruit wood was crushed, 10 L of acetone was added, and the mixture was heated under reflux at about 75 ° C. for extraction for 3 hours, cooled, filtered, and then subjected to solid / liquid separation, and the separated extract was decompressed. After concentration and removal of acetone, the concentrated and concentrated extract was passed through silica gel column chromatography (manufactured by Merck & Co., Inc.) and sequentially eluted with each of the following extraction solvents (benzene, chloroform, ethyl acetate, acetone, methanol), Obtain the eluate. When the obtained elution fractions were screened for antibacterial activity, a strong activity was observed in the chloroform elution fraction. Therefore, when a component search was performed on this eluted fraction, it was confirmed that altocarpine was contained as a main component, and as a result of conducting an antibacterial test again on altocarpine, a strong antibacterial effect was found.
【0025】実施例2:アルトカルピンの精製
ジャックフルーツの木材約50gを粉砕して、アセトン
500mlを加え、約75℃にて3時間、加熱還流抽出
し、冷却後、濾過して固・液分離を行い、分離した抽出
液を減圧濃縮して、アセトン除去後、濃縮したエキス
を、シリカゲルカラムクロマトグラフィー(メルク社
製)ベンゼン:酢酸エチル=10:1により溶出し、溶
出液を得る。次にこの溶出液を再結晶によりアルトカル
ピンを約86mg得る。Example 2: Purification of altocarpine About 50 g of jackfruit wood was crushed, 500 ml of acetone was added, and the mixture was heated under reflux extraction at about 75 ° C. for 3 hours, cooled, filtered, and then solid-liquid separation was performed. The separated extract is concentrated under reduced pressure to remove acetone, and then the concentrated extract is eluted with silica gel column chromatography (Merck & Co., Inc.) benzene: ethyl acetate = 10: 1 to obtain an eluate. Then, the eluate is recrystallized to obtain about 86 mg of altocarpine.
【0026】 実施例3
:黄色ブドウ球菌、枯草菌に対す
る生育阻害試験
[試験菌]
1.スタフィロコッカス アウレウス(Staphylococcus aureus)黄色ブド
ウ球菌:(ATCC6538)
2.ハ゛シラス サフ゛チルス(Bacillus subtilis)枯草菌:(ATCC93
72)
[使用培地]
Brain Heart Infusion Broth"栄研"(以下、BHI)3
7gを精製水1000mlに溶かし、121℃、15分
間加圧滅菌する。
[試料菌液の調製]
上記培地10mlに試験菌1白金耳を加え37℃で18
時間培養し、これを同培地で生菌数が約106になるよ
う希釈したものを試料菌液とする。
[検体の調製]
アルトカルピン1mgをジメチルスルホオキシド(以
下、DMSO)1mlに溶解して、検体液とし、パラオ
キシ安息香酸メチルについても同様に行った。
[試験方法]
BHI培地1.8mlに検体液0.1ml及び試料菌液
0.1mlを加え、37℃で24時間嫌気培養した後
(Gas Pack BBL製)、寒天平板(大五栄養
製)に画線し、残存菌を確認し、倍数希釈法にて、最小
発育阻止濃度(ppm)判定した。結果は表1に示し
た。 [0026] Example 3: Staphylococcus aureus, the growth inhibition test against B. subtilis [test bacteria] 1. Staphylococcus aureus Staphylococcus aureus: (ATCC6538) 2. Bacillus subtilis Bacillus subtilis: (ATCC93
72) [Used medium] Brain Heart Infusion Broth "Eiken" (BHI) 3
Dissolve 7 g in 1000 ml of purified water, and sterilize under pressure at 121 ° C. for 15 minutes. [Preparation of Sample Bacterial Fluid] To 10 ml of the above medium, 1 platinum loop of the test bacterium was added, and the mixture was incubated at 37 ° C.
After culturing for a period of time and diluting this with the same medium to a viable cell count of about 10 6 , it is used as a sample bacterial solution. [Preparation of Specimen] 1 mg of altocarpine was dissolved in 1 ml of dimethyl sulfoxide (hereinafter, DMSO) to prepare a specimen solution, and methyl paraoxybenzoate was similarly subjected. [Test Method] After adding 0.1 ml of the sample solution and 0.1 ml of the sample bacterial solution to 1.8 ml of BHI medium and anaerobically culturing at 37 ° C. for 24 hours (manufactured by Gas Pack BBL), agar plates (manufactured by Daigo Nutrition) were added. After streaking and confirming the remaining bacteria, the minimum inhibitory concentration (ppm) was determined by the multiple dilution method. The results are shown in Table 1.
【0027】[0027]
【表1】 [Table 1]
【0028】[試験結果]
アルトカルピンは、黄色ブドウ球菌、枯草菌に対しての
最少生育阻止濃度は、1ppmと判定でき、非常に少量
で生育阻害効果を有することが確認できた。尚、対照と
して用いたパラオキシ安息香酸メチルと比較しても、非
常に強い生育阻害効果を有することが確認できた。 [0028] [Test Results] Alto pilocarpine is minimum growth inhibitory concentration against Staphylococcus aureus, Bacillus subtilis, 1 ppm and can be determined, was confirmed to have a growth inhibitory effect in very small quantities. It was confirmed that it has a very strong growth inhibitory effect as compared with methyl paraoxybenzoate used as a control.
【0029】 実施例4
:プロピオニバクテリウム アク
ネス菌に対する生育阻害試験
[被験菌株の調製]
プロピオニバクテリウム アクネス菌(Propionibacter
ium acnes、以下、PA菌)は、当研究室で健康なボラ
ンティアの全額より分離、同定した株で懸濁液(2.0×1
09個/ml)として凍結保存している株を用い、液体培地
で10倍に希釈して被験菌液とした。
[液体培地]
*1 Nutrient broth(Difco) 0.5g
酵母エキス 0.3g
Tween 80 0.2ml
精製水 100ml
[検体の調製]
アルトカルピン1mgをDMSO1mlに溶解して、検
体液とする。
[試験方法]
液体培地1.8mlに検体液0.1ml及び被験菌液
0.1mlを加え、37℃で7日間嫌気培養後(Gas
Pack BBL製)、培養液10μlをGAM寒天
培地(日水製薬製)に画線し、37℃,48時間嫌気培
養後、残存菌を確認し、倍数希釈法にて、最小発育阻止
濃度(ppm)判定した。結果は表2に示した。 [0029] Example 4: Growth inhibition test against Propionibacterium acnes [Preparation of test strains] Propionibacterium acnes (Propionibacter
ium acnes (hereinafter referred to as "PA bacterium") is a suspension (2.0 x 1) of the strain identified and isolated from the total amount of healthy volunteers in our laboratory.
( 9 cells / ml), the strain stored frozen was used and diluted 10-fold with a liquid medium to give a test bacterial solution. [Liquid medium] * 1 Nutrient broth (Difco) 0.5 g Yeast extract 0.3 g Tween 80 0.2 ml Purified water 100 ml [Preparation of sample] 1 mg of altocarpine is dissolved in 1 ml of DMSO to prepare a sample solution. [Test method] To 1.8 ml of liquid medium, 0.1 ml of the sample solution and 0.1 ml of the test bacterial solution were added, followed by anaerobic culture at 37 ° C. for 7 days (Gas
Pack BBL), 10 μl of the culture solution was streaked on GAM agar medium (Nissui Pharmaceutical Co., Ltd.), and after anaerobic culture at 37 ° C. for 48 hours, residual bacteria were confirmed, and the minimum inhibitory concentration (ppm) was determined by the multiple dilution method. ) Judged. The results are shown in Table 2.
【0030】[0030]
【表2】 [Table 2]
【0031】[試験結果]
アルトカルピンのPA菌に対する最少生育阻止濃度は、
19.5ppmと判定できるが、更に2.4ppmでも
生育阻害効果を有することが認められた。よって、アル
トカルピンは非常に少量でPA菌に対する生育阻害効果
を有することが確認できた。 The minimum growth inhibitory concentration for PA bacteria [Test Results] Alto pilocarpine is
Although it could be determined to be 19.5 ppm, it was also confirmed that the growth inhibitory effect was obtained even at 2.4 ppm. Therefore, it was confirmed that altocarpine had a growth inhibitory effect on PA bacteria even in a very small amount.
【0032】 実施例5
:ピティロスポルム オバーレ菌
に対する生育阻害試験
[被験菌株]
ピティロスポルム・オバーレ菌(Pityrosporum ovale、
以下、PO菌)は、当研究室で健康なボランティアの全
額より分離、同定した株で懸濁液(1.6×106個/ml)と
して凍結保存している株を用い、液体培地で10倍に希
釈して被験菌液とした。
[液体培地]
*2 グルコ−ス 2g
モノオレイン酸ホ゜リオキシエチレンク゛リセリン(5EO) 5ml
ポテト抽出液 100ml
[検体の調製]
アルトカルピン1mgをDMSO1mlに溶解して、検
体液とする。
[試験方法]
液体培地1.8mlに検体液0.1ml及び被験菌液
0.1mlを加え、30℃、2日間嫌気培養後(Gas
Pack BBL製)、培養液10μlを5%のモノ
オレイン酸ポリオキシエチレングリセリン(5EO)を
含むポテトデキストロ−ス寒天培地(日水製薬製)にに
画線し、30℃、24時間嫌気培養後、残存菌を確認
し、倍数希釈法にて、最小発育阻止濃度(ppm)判定
した。結果は表3に示した。 [0032] Example 5: Pitirosuporumu growth inhibition test against Obare bacteria [test strains] Pitirosuporumu-Obare fungus (Pityrosporum ovale,
(PO bacteria) is a strain that was isolated and identified from the total amount of healthy volunteers in our laboratory and frozen and stored as a suspension (1.6 x 10 6 cells / ml). Was diluted to give a test bacterial solution. [Liquid medium] * 2 Glucose 2 g Polyoxyethyleneglycerin monooleate (5EO) 5 ml Potato extract 100 ml [Preparation of sample] 1 mg of altocarpine is dissolved in 1 ml of DMSO to prepare a sample solution. [Test Method] To 1.8 ml of liquid medium, 0.1 ml of the sample solution and 0.1 ml of the test bacterial solution were added, and after anaerobic culture at 30 ° C. for 2 days (Gas
(Pak BBL), 10 μl of the culture solution was streaked on a potato dextro-agar medium (manufactured by Nissui Pharmaceutical Co., Ltd.) containing 5% polyoxyethylene glycerin monooleate (5EO), and anaerobically cultured at 30 ° C. for 24 hours. After that, the remaining bacteria were confirmed, and the minimum inhibitory concentration (ppm) was determined by the multiple dilution method. The results are shown in Table 3.
【0033】[0033]
【表3】 [Table 3]
【0034】[試験結果]
アルトカルピンのPO菌に対する最少生育阻止濃度は、
2.0ppmと判定できるが、アルトカルピンは更に低
濃度で生育阻害効果を有することが認められ、よって、
アルトカルピンは非常に少量でPO菌に対する生育阻害
効果を有することが確認できた。 [0034] [Test Results] minimum growth inhibitory concentration for PO bacteria Alto pilocarpine is
Although it can be determined to be 2.0 ppm, it was confirmed that altocarpine has a growth inhibitory effect at a lower concentration.
It was confirmed that altocarpine has a growth inhibitory effect on PO bacteria even in a very small amount.
【0035】 実施例6
:ニキビ及び肌荒れ改善試験
「試験方法及び評価方法」
下記表4に示した本発明品及び比較品のクリームについ
て、ニキビ症の成人男女20名をパネラーとして、毎日
朝と夜の2回、適量を手に取り、顔に塗布してもらい、
あとは自由に2カ月間に渡って連続使用効果試験を実施
した。尚、評価方法は次の基準にて行い、又、結果は表
5の如くで表中の数値は人数を表す。
「ニキビ改善効果」
有 効:ニキビが改善された。
やや有効:ニキビがやや改善された。
無 効:使用前と変化なし。
「肌荒れ改善効果」
有 効:肌荒れが改善された。
やや有効:肌荒れがやや改善された。
無 効:使用前と変化なし。 [0035] Example 6: For acne and skin roughness improvement test "test method and the evaluation method" in Table 4 below to the product of the present invention and comparative product of cream shown, as a panelist adult men and women 20 people acne disease, night and morning every day 2 times, take an appropriate amount and apply it on your face,
After that, a continuous use effect test was freely conducted for two months. The evaluation method was carried out according to the following criteria, and the results are shown in Table 5 and the numerical values in the table represent the number of people. "Acne improvement effect" Effective: Acne was improved. Slightly effective: The acne was slightly improved. Ineffective: No change from before use. "Rough skin improvement effect" Effective: Rough skin was improved. Slightly effective: Rough skin was slightly improved. Ineffective: No change from before use.
【0036】[0036]
【表4】 [Table 4]
【0037】[0037]
【表5】 [Table 5]
【0038】[試験結果]
結果は表5の如く、本発明品1〜2のアルトカルピンを
配合したクリームは、ニキビが改善され、又、肌荒れに
ついても比較品に比べて良好な結果が得られた。 [0038] [Test Results] The results are as shown in Table 5, cream formulated with alto Karpin of the present invention product 1-2, acne is improved, also, good results as compared with the comparative product also rough skin It was
【0039】 実施例7 :フケ抑制及びカユミ改善試験 [0039] Example 7: antidandruff and itching improved test
【0040】
「試験方法及び評価方法」
下記表6に示した本発明品及び比較品のシャンプーにつ
いて、フケ症又はフケ症に伴うのカユミを持つ成人男女
20名をパネラーとして、毎日夜入浴時に1回、適量を
手に取り、洗髪してもらい、あとは自由に2カ月間に渡
って連続使用効果試験を実施した。又、同様に下記表7
に示した本発明品及び比較品のヘアトニックについて、
フケ症又はフケ症に伴うのカユミを持つ成人男女20名
をパネラーとして、毎日朝と夜の2回、適量を手に取
り、頭髪に塗布してもらい、あとは自由に2カ月間に渡
って連続使用効果試験を実施した。評価方法は次の基準
にて行い、結果は表8の如くで表中の数値は人数を表
す。
「フケ抑制効果」
有 効:フケが抑制された。
やや有効:フケがやや抑制された。
無 効:使用前と変化なし。
「カユミ改善効果」
有 効:カユミが改善された。
やや有効:カユミがやや改善された。
無 効:使用前と変化なし。 [ Test Method and Evaluation Method ] With respect to the shampoos of the present invention product and the comparative product shown in Table 6 below, 20 adult men and women with dandruff or itchiness associated with dandruff were used as panelists every day at night for bathing. Each time, an appropriate amount was picked up, and the hair was washed. After that, the continuous use effect test was conducted freely for 2 months. Similarly, the following Table 7
Regarding the hair tonic of the present invention product and the comparative product shown in
As panelists, 20 adult men and women with dandruff or itchy acne associated with dandruff, picked up an appropriate amount twice daily in the morning and at night, had it applied to the hair, and then freely for 2 months. A continuous use effect test was conducted. The evaluation method was carried out according to the following criteria. The results are shown in Table 8 and the numerical values in the table represent the number of people. "Dandruff control effect" Effective: The dander was suppressed. Slightly effective: Dandruff was slightly suppressed. Ineffective: No change from before use. "Kayumi improvement effect" Effective: Kayumi was improved. Slightly effective: Kayumi improved slightly. Ineffective: No change from before use.
【0041】[0041]
【表6】 [Table 6]
【0042】[0042]
【表7】 [Table 7]
【0043】[0043]
【表8】 [Table 8]
【0044】[試験結果]
結果は表8の如く、本発明品1〜2のアルトカルピンを
配合したシャンプー又はヘアトニックは、フケ抑制及び
カユミが改善されており、比較品と比べても、非常に良
好な結果が得られた。 [0044] [Test Results] The results are as shown in Table 8, the present invention product 1-2 shampoo or hair tonic formulated with Alto pilocarpine is antidandruff and itching improved, as compared with the comparative product, very Very good results were obtained.
【0045】 実施例8
:安全性試験
[皮膚一次刺激性試験]
アルトカルピンの粉末10mgを50%1,3−ブチレ
ングリコール水溶液10mlに溶解した液、又、アルト
カルピン粉末10mgを60%エタノール水溶液10m
lに溶解した液を背部を除毛した兎(1群3匹,体重3,
800g前後)の皮膚に貼付した。判定は貼付後24,48,72
時間に一次刺激性の評点法により紅斑及び浮腫を指標と
して行った。その結果、すべての動物において、何等、
紅斑及び浮腫を認めず陰性と判定された。
[皮膚累積刺激性試験]
同様に、アルトカルピンの粉末10mgを50%1,3
−ブチレングリコール水溶液10mlに溶解した液、
又、アルトカルピン粉末10mgを60%エタノール水
溶液10mlに溶解した液を側腹部を除毛(2×4cm2)
したハートレー系モルモット(雌性,1群5匹,体重32
0g前後)の皮膚に1日1回,週5回,0.5ml/動物当り
を塗布した。塗布は4週に渡って、又、除毛は各週の最
終塗布日に行った。判定は、各週の最終日の翌日に一次
刺激性の評点法により紅斑および浮腫を指標として行っ
た。その結果、すべての動物において、塗布後1〜4週
目に渡って何等、紅斑及び浮腫を認めず陰性と判定され
た。
[急性毒性試験]
同様に、アルトカルピンの粉末を試験前、4時間絶食さ
せたddy系マウス(1群5匹,体重30g)に2,000mg/kg
量経口投与し、毒性症状の発現、程度などを経時的に観
察した。その結果、すべてのマウスにおいて14日間何等
異常を認めず、解剖の結果も異常がなかった。LD50は2,
000mg/kg以上と判定された。 [0045] Example 8: Safety test solution prepared by dissolving powder 10mg of [primary skin irritation test] Alto pilocarpine to 50% 1,3-butylene glycol aqueous solution 10 ml, also Alto pilocarpine powder 10mg of 60% aqueous ethanol solution 10m
Rabbits with hair removed from the solution (1 group 3 animals, body weight 3,
About 800 g) was applied to the skin. Judgment is 24, 48, 72 after attachment
Erythema and edema were used as indices by the scoring method of primary irritation during time. As a result, in all animals,
Neither erythema nor edema was observed and the result was negative. [Skin cumulative irritation test] Similarly, 10 mg of altocarpine powder was added to 50% 1,3
A liquid dissolved in 10 ml of an aqueous solution of butylene glycol,
Also, a solution of 10 mg of altocarpine powder dissolved in 10 ml of 60% aqueous ethanol solution was shaved on the flank (2 x 4 cm2).
Hartley guinea pigs (female, 5 per group, weight 32)
(About 0 g) was applied to the skin once a day, 5 times a week, 0.5 ml / animal. The application was carried out for 4 weeks, and the hair removal was performed on the last application day of each week. Judgment was performed on the day after the last day of each week, using erythema and edema as an index by the primary irritation scoring method. As a result, in all animals, erythema and edema were not observed for 1 to 4 weeks after application, and it was determined to be negative. [Acute toxicity test] Similarly, 2,000 mg / kg to ddy mice (5 mice per group, body weight 30 g) fasted for 4 hours with altocarpine powder before the test.
The amount was orally administered, and the onset and degree of toxicity were observed over time. As a result, no abnormality was observed in all mice for 14 days, and there was no abnormality in the autopsy result. LD50 is 2,
It was determined to be 000 mg / kg or more.
【0046】
以下に実施例を示し、本発明の利用方法を
更に詳述するが、本発明は以下の実施例に特定されるこ
とはなく、各種の食品、化粧品類、医薬品、医薬部外品
等に含有・配合して用いることが出来る。尚、各実施例
は各製品の製造における常法により製造したもので良
く、配合量のみを示した。 [0046] the following examples, but further detailing the usage of the present invention, the present invention is not specified in the examples below, various foods, cosmetics, pharmaceuticals, quasi-drugs Etc. can be used by being contained and compounded. In addition, each Example may be manufactured by a conventional method for manufacturing each product, and only the compounding amount is shown.
【0047】 実施例9:コールドクリーム 重 量% 1.サラシミツロウ 11.0 2.流動パラフィン 22.0 3.ラノリン 10.0 4.アーモンド油 15.0 5.ホウ砂 0.5 6.アルトカルピン 0.4 7.香料 適 量 8.精製水 100とする残余 [0047] Example 9: cold cream Weight% 1. White beeswax 11.0 2. Liquid paraffin 22.0 3. Lanolin 10.0 4. Almond oil 15.0 5. Borax 0.5 6. Altocalpine 0.4 7. Suitable amount of perfume 8. Residue of purified water 100
【0048】 実施例10:ローション 重 量% 1.ソルビット 2.0 2.1,3−ブチレングリコール 2.0 3.ポリエチレングリコール1000 1.0 4.ホ゜リオキシエチレンオレイルエーテル(25E.O.) 2.0 5.エタノール 10.0 6.アルトカルピン 1.0 7.香料 適 量 8.精製水 100とする残余 [0048] Example 10: Lotion Weight% 1. Sorbit 2.0 2.1,3-butylene glycol 2.0 3. Polyethylene glycol 1000 1.0 4. Polyoxyethylene oleyl ether (25E.O.) 2.0 5. Ethanol 10.0 6. Altocalpine 1.0 7. Suitable amount of perfume 8. Residue of purified water 100
【0049】 実施例11:パン 重 量% 1.小麦粉 94.0 2.食塩 0.9 3.ブドウ糖 5.0 4.アルトカルピン 0.1 [0049] Example 11: Bread Weight% 1. Flour 94.0 2. Salt 0.9 3. Glucose 5.0 4. Altocalpin 0.1
【0050】 実施例12:ソーセージ 重 量% 1.ひき肉 94.0 2.鶏卵 5.0 3.香辛料 0.3 4.調味料 0.5 5.アルトカルピン 0.2 [0050] Example 12: sausage Weight% 1. Ground meat 94.0 2. Chicken egg 5.0 3. Spice 0.3 4. Seasoning 0.5 5. Altocarpin 0.2
【0051】 実施例13:果汁飲料 重 量% 1.ブドウ糖液糖 33.0 2.グレープフルーツ果汁 65.0 3.香料 1.0 4.アルトカルピン 1.0 5.酸味料 適 量 [0051] Example 13: fruit juice drinks Weight% 1. Glucose liquid sugar 33.0 2. Grapefruit juice 65.0 3. Fragrance 1.0 4. Altocalpine 1.0 5. Acidulant Suitable amount
【0052】 実施例14:ガム 重 量% 1.メントールミクロン 32.0 2.グレープフルーツフレーバー 65.0 3.アルトカルピン 3.0 [0052] Example 14: Gum Weight% 1. Menthol Micron 32.0 2. Grapefruit flavor 65.0 3. Altocalpin 3.0
【0053】[0053]
【発明の効果】本発明のアルトカルピンは、各種の細菌
(黄色ブドウ球菌、枯草菌、ニキビ菌、フケ菌)に対し
て、増殖抑制作用を有し、更に人又は動物に対して安全
である。従って、抗菌・防腐剤として用いれば、各種形
態の製剤・製品の腐敗・汚染防止することができるの
で、各種形態の経口薬剤、繊維製品(シーツ類、衣
類)、又、衛生綿類、除菌用クロス等の不織布に、更に
一般的な飲食類に適用できる。又、化粧料として用いれ
ば、ニキビや肌荒れを改善し、更にフケやカユミを抑制
する効果を有するので、医薬品・医薬部外品或は化粧品
分野(人及びその他の動物用に用いる各種製剤も含む)
の各種化粧料に適用することができる。更には、う蝕原
菌等の口腔用菌類に対しても抗菌作用を有するものと考
えられ、虫歯、歯周病といった症状の予防にも利用可能
である。INDUSTRIAL APPLICABILITY The altocarpine of the present invention has a growth inhibitory action against various bacteria (Staphylococcus aureus, Bacillus subtilis, acne bacterium, dandruff bacterium) and is safe for humans or animals. . Therefore, when it is used as an antibacterial / antiseptic agent, it can prevent spoilage / contamination of various forms of preparations / products. Therefore, various forms of oral drugs, textile products (sheets, clothes), sanitary cotton, sanitization, etc. It can be applied to non-woven fabrics such as business cloth, and to general food and drink. Further, when used as a cosmetic, it has the effects of improving acne and rough skin, and suppressing dandruff and itchiness. Therefore, it also includes pharmaceuticals, quasi-drugs, and cosmetics (including various preparations used for humans and other animals. )
It can be applied to various cosmetics. Furthermore, it is considered to have an antibacterial action against oral fungi such as cariogenic bacteria and can be used for the prevention of symptoms such as tooth decay and periodontal disease.
フロントページの続き (51)Int.Cl.7 識別記号 FI A61K 7/00 A61K 7/00 Y 7/06 7/06 7/48 7/48 31/352 31/352 A61P 31/04 A61P 31/04 (56)参考文献 特開 平6−157267(JP,A) 特開 昭63−141907(JP,A) K.M.Renuka Prasad et al,PURICATION AND CHRACTERIZATIO N OF A PROTEASEFRO M JACKFRUIT LATEX, Phytochemisry,1999年, Vol.29,No.6,pp.1763− 1766 Phytotherapy Rese arch,1990,Vol.4,No. 6,pp.235−236 (58)調査した分野(Int.Cl.7,DB名) A61K 35/78 A61K 7/00 BIOSIS(DIALOG) CA(STN) MEDLINE(STN)Continuation of the front page (51) Int.Cl. 7 Identification code FI A61K 7/00 A61K 7/00 Y 7/06 7/06 7/48 7/48 31/352 31/352 A61P 31/04 A61P 31/04 (56) References JP-A-6-157267 (JP, A) JP-A-63-141907 (JP, A) K.K. M. Renuka Prasad et al, PURICATION AND CHRACTERIZATIO N OF A PROTEASEFROM M JACKFRUIT LATEX, Phytochemistry, 1999, Vol. 29, No. 6, pp. 1763-1766 Phytotherapy Research arch, 1990, Vol. 4, No. 6, pp. 235-236 (58) Fields investigated (Int.Cl. 7 , DB name) A61K 35/78 A61K 7/00 BIOSIS (DIALOG) CA (STN) MEDLINE (STN)
Claims (4)
する抗菌・防腐剤。1. An antibacterial / antiseptic agent containing altocarpine.
ケ菌に対して増殖抑制作用を有する請求項1記載の抗菌
・防腐剤。2. The antibacterial and antiseptic agent according to claim 1, which has a growth inhibitory action against Staphylococcus aureus, Bacillus subtilis, Acne and Dandruff.
する皮膚化粧料。3. A skin cosmetic, which comprises altocarpine.
する頭髪化粧料。4. A hair cosmetic composition containing altocarpine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23226694A JP3385293B2 (en) | 1994-08-31 | 1994-08-31 | Altocarpine-containing antibacterial and preservatives and cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23226694A JP3385293B2 (en) | 1994-08-31 | 1994-08-31 | Altocarpine-containing antibacterial and preservatives and cosmetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002207838A Division JP2003095852A (en) | 2002-07-17 | 2002-07-17 | Antibacterial agent containing sophoraflavanone g and cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0873372A JPH0873372A (en) | 1996-03-19 |
| JP3385293B2 true JP3385293B2 (en) | 2003-03-10 |
Family
ID=16936561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP23226694A Expired - Fee Related JP3385293B2 (en) | 1994-08-31 | 1994-08-31 | Altocarpine-containing antibacterial and preservatives and cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3385293B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100311199B1 (en) * | 1996-07-12 | 2001-12-15 | 성재갑 | Compositions with inhibitory activity of 5-alpha-reductase and antibacterial activity against propionibacterium acnes |
| US20030035784A1 (en) | 2001-03-05 | 2003-02-20 | Kao Corporation | Hair cosmetic, aminocarboxylic acid amide and method for producing the same |
| JP5001847B2 (en) | 2005-09-27 | 2012-08-15 | 旭化成ケミカルズ株式会社 | Cellooligosaccharide-containing composition |
| KR100722673B1 (en) * | 2005-12-27 | 2007-05-29 | 주식회사 코리아나화장품 | Cosmetic composition containing glyceryl caprylate and ginseng extract as preservatives |
| JP2008044897A (en) * | 2006-08-17 | 2008-02-28 | Kansai Koso Co Ltd | Artocarpin derivative and artocarpin analogue, hair-growing composition and brightening cosmetic composition each containing the same, and pharmaceutical as anticancer agent, anti-inflammatory/analgesic agent, antipyretic agent or antiallergic agent, and pharmacuetical for treating pigmentary dermatosis, each containing the same |
| CN113475532A (en) * | 2021-07-28 | 2021-10-08 | 广州毅田生物技术有限公司 | Metarhizium anisopliae compound biological insecticide and application thereof |
-
1994
- 1994-08-31 JP JP23226694A patent/JP3385293B2/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| K.M.Renuka Prasad et al,PURICATION AND CHRACTERIZATION OF A PROTEASEFROM JACKFRUIT LATEX,Phytochemisry,1999年,Vol.29,No.6,pp.1763−1766 |
| Phytotherapy Research,1990,Vol.4,No.6,pp.235−236 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0873372A (en) | 1996-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4231559B2 (en) | Lipoxygenase inhibitor | |
| JP3327699B2 (en) | Antibacterial / preservative and cosmetics containing kujin extract | |
| JP2000086510A (en) | Histamine release inhibitor | |
| JPH08325156A (en) | Skin preparation for external use, drink and food product containing steviol glycoside | |
| AU2018382466B2 (en) | Propanediol monoacetate mononitrate | |
| JPH10120583A (en) | Anti-allergic agent, chemical mediator release inhibitor and anti-allergic cosmetic, pharmaceutical and food containing the same | |
| JP2013155158A (en) | Antimicrobial agent composition and method for producing the same | |
| JP5716385B2 (en) | 3,5-dihydroxy-2-mentenylstilbene, plant extract containing the same, method for collecting the same and application thereof | |
| JPH0987188A (en) | External skin agent and bath agent | |
| JPH09118611A (en) | Cosmetics | |
| JP3385293B2 (en) | Altocarpine-containing antibacterial and preservatives and cosmetics | |
| KR101433823B1 (en) | External Composition for Skin Using an Extract or a Fraction of Padina arborescens | |
| JP3501855B2 (en) | Antibacterial / preservative and cosmetics containing jackfruit extract | |
| JPH03112912A (en) | Cosmetic composition | |
| JP2024102278A (en) | Use of dianhydrohexitol to eliminate cosmetic effects of acne, dandruff and bad odors | |
| JP2009024023A (en) | Lipoxygenase inhibitor | |
| JP2990611B2 (en) | Extraction method for dandruff growth inhibitory components | |
| KR100536550B1 (en) | Composition containing moutan root bark extract as active ingredient | |
| JP2003095852A (en) | Antibacterial agent containing sophoraflavanone g and cosmetic | |
| CN110547975B (en) | Cosmetic composition containing epipinephrine | |
| KR20230080174A (en) | Composition for anti-oxidation, anti-inflammation, and acne comprising extracts unripe fruit derived from Poncirus trifoliata | |
| KR101042690B1 (en) | Anti-aging and Anti-wrinkle Composition Containing Chonnahichomi Extract as an Active Ingredient | |
| JPH10203991A (en) | Preparation for external use for skin | |
| JP2004307385A (en) | Antibacterial agent | |
| JPH10298095A (en) | Antibacterial agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313532 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081227 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091227 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091227 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101227 Year of fee payment: 8 |
|
| LAPS | Cancellation because of no payment of annual fees |